Getting latest data loading
Home / Morning Report / Morning Report

This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.

Morning Report - 11 February 2022

Yesterday’s UK 100 Leaders Price (p) % Chg
INFORMA PLC 615.8 7.4%
ANTOFAGASTA PLC 1,344.5 4.2%
AIRTEL AFRICA PLC 144.0 3.5%
ASTRAZENECA PLC 8,650.0 3.4%
POLYMETAL INTERNATIONAL PLC 1,128.0 3.3%
Yesterday’s UK 100 Laggards Price (p) % Chg
EVRAZ PLC 431.7 -3.0%
DECHRA PHARMACEUTICALS PLC 3890.0 -2.2%
RELX PLC 2267.0 -1.9%
INTERMEDIATE CAPITAL GROUP 1857.0 -1.8%
ROYAL MAIL PLC 440.6 -1.8%
Major World Indices Price % Chg 1 YEAR
UK 100 INDEX 7,672 0.4% 17.6%
DOW JONES INDUS. AVG 35,316 -1.3% 12.3%
DAX INDEX 15,490 0.1% 11.2%
NIKKEI 225 27,696 0.4% -6.3%
S&P/ASX 200 INDEX 7,288 0.3% 6.4%
Commodities Units Price % Chg
WTI Crude Oil (Nymex) USD/bbl. 89.60 -0.07%
Brent Crude (ICE) USD/bbl. 91.31 -0.26%
Gold Spot USD/t oz. 1,835 0.1%
Copper (Comex) USd/lb. 465 0.9%
The UK 100 is called to open -60 points today at 7612. 

1 Day; 12 Months

Click graph to enlarge

Markets Overview:

 

The UK 100 is called to open -60 points today at 7612. The UK 100 looks set for a pullback today after a week of pure positivity, this comes after US inflation rates hit 7.5% in January, accelerating at a rate faster than had been expected.  US markets struggled yesterday, with the Dow Jones down 526 points (1.5%) at 35,242 and the S&P 500 off 83 points (1.8%) at 4,504.  In Asia this morning, Tokyo has avoided the fall this morning, albeit through a market holiday while in Hong Kong, the Hang Seng index is down 151 points or 0.6% at 24,772.

 

 

 

Company News & Broker Comments:

 

Company News:

British American Tobacco reported a 7% rise in Q4 adjusted revenue to $25.7bn as more people shifted over to e-cigarettes and oral nicotine amid health concerns during the pandemic. They also announced a dividend increase of 1.0% to 217.8p and a £2bn share repurchase programme for 2022.

 

 

Deliveroo will trial its "Deliveroo Hop" rapid grocery service with supermarket Waitrose.

 

 

GlaxoSmithKline's antibody-based COVID-19 therapy developed by GSK & Vir Biotechnology retains neutralising activity against the emerging BA.2 form of the Omicron coronavirus variant studies have found.

 

 

Tate & Lyle sees FY performance of continuing operations to be stronger as their Q3 trading was in line with expectations.

 

 

Vodafone has rejected a preliminary approach for its Italian business from Iliad and Apax partners worth more than 11bn euros.

 

Broker Comments

Jefferies Downgrades Victrex to Hold from Buy (3 Buys / 6 Holds / 1 Sell)

 

 

Jefferies Upgrades Smiths Group to Buy from Hold (3 Buys / 5 Holds / 0 Sells)

 

 

Jefferies Upgrades Weir Group to Buy from Hold (7 Buys / 4 Holds / 0 Sells)

 

 

RPT/DZ Upgrades AstraZeneca to Hold from Sell (13 Buys / 3 Holds / 0 Sells)

 

 

Reporting Today:

 

British American Tobacco

 

Electrocomponents

 

 

 

 

Reporting Friday:

 

None

 

 

 

 

In Focus Today:

 

UK Gross Domestic Product

 

UK Industrial Production

 

UK Manufacturing Production

 

US Michigan Consumer Sentiment Index

 

US Fed Monetary Policy Report

 

 

 

 

Next Week's Ex-Dividends:

 

FTSE 100:

Imperial Brands

 

BP

 

Shell

 

Pershing Square Holdings

FTSE 250:

Beazley

 

Hipgnosis Songs Fund

 

BlackRock Throgmorton Trust

 

Murray Income Trust

 

NCC Group

 

For any help you may require placing trades or in terms of market information, put a call in to our trading floor – it’s all part of the service.


Back to Top

This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.


Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance.

Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when spread betting and/or trading CFDs with this provider. You should consider whether you understand how spread bets and CFDs work and whether you can afford to take the high risk of losing your money.
.